Immedica Pharma AB

North America Legal Chronicle. August 2, 2023

Immedica Pharma’s Acquisition of Pegzilarginase Assets from Aeglea

By Leila Ahmed

Davis Polk & Wardwell advised Immedica Pharma AB on the transaction. Immedica Pharma AB announced its acquisition from Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) of all assets related...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Europe Legal Chronicle. May 2, 2022

Immedica Pharma AB’s Licence and Supply Agreement With Actinium Pharmaceuticals, Inc

By Giulia Di Palma

Gowling WLG advised Swedish pharmaceutical company Immedica Pharma AB on the deal. Immedica signed a licence and supply agreement with Actinium Pharmaceuticals, Inc to commercialise Iomab-B, an...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

May River Capital’s Acquisition of Cashco

Kodiak Gas Services’ $189.57 Million Common Stock Offering

Spectro Cloud’s $75 Million Series C Funding Round

YPF Luz’s US$420 Million Notes Issuance

360 Energy Solar’s US$22 Million Green Notes Issuance

Eneva’s Acquisition of Tevisa Termelétrica Viana, Povoação Energia, Linhares Brasil Energia Participações, and 50% of Geradora de Energia do Maranhão

Zorlu Enerji’s US$200 Million Sustainability-Linked Eurobond Issuance

Bilbolaget’s Land Acquisition

Vier Gas Transport’s €500 Million Bond Issuance

Tamweely’s EGP 5 Billion Securitization Program

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Camusat Holding’s €81 Million Mezzanine Investment Round

Commercial Bank of Dubai’s US$500 Million Bond Issuance

Medianova’s Investment Round

Lulu Retail Holdings Plc’s $1.72 Billion IPO On ADX

AGC Automotive (Thailand) Co., Ltd. v. Renewable Energy for Thai People Co., Ltd.

Profectus Capital’s Non-Convertible Debentures Issuance

NBL and LK Group’s Investment in WNBL

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

Immedica Pharma’s Acquisition of Pegzilarginase Assets from Aeglea

Standard 1 Year Membership Required

Immedica Pharma AB’s Licence and Supply Agreement With Actinium Pharmaceuticals, Inc

Standard 1 Year Membership Required